For instance, in October 2024, Novo Nordisk made significant strides with Rybelsus, as the company announced its plan to expand the drugs indication to prevent major adverse cardiovascular events (MACE) in patients with Type 2 diabetes, cardiovascular disease (CVD), or chronic kidney disease (CKD)
Meeting: Annual Meeting of the European Association for the Study of Diabetes (EASD) Never miss a breakthrough: Join the SciTechDaily newsletter
Your sleep feels light or broken, and you wake up not feeling refreshed
On the other hand, RCD requires the genetically encoded machinery, which is frequently quite complex and sophisticated
They are regulated primarily at the state level through boards of pharmacy, with additional federal oversight for 503B outsourcing facilities
in 2025, she posted a selfie on Instagram showing off her flat stomach